documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
2,099 rows where document_type = "Other" and posted_year = 2010 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-E-0662-0001 | FDA | FDA-2010-E-0662 | Aventis Pharma S.A. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:23Z | 0 | 0 | 0900006480bc2a98 | ||
| FDA-2010-E-0656-0001 | FDA | FDA-2010-E-0656 | Amgen Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-08-11T04:43:36Z | 0 | 0 | 0900006480bc285b | ||
| FDA-2010-E-0656-0003 | FDA | FDA-2010-E-0656 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2010-12-30T16:57:57Z | 0 | 0 | 0900006480bc28a7 | ||
| FDA-2010-E-0659-0001 | FDA | FDA-2010-E-0659 | Amgen Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:21Z | 0 | 0 | 0900006480bc28b0 | ||
| FDA-2010-E-0662-0002 | FDA | FDA-2010-E-0662 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-08-11T01:39:02Z | 0 | 0 | 0900006480bc2a9a | ||
| FDA-2010-E-0661-0002 | FDA | FDA-2010-E-0661 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:23Z | 0 | 0 | 0900006480bc2a28 | ||
| FDA-2010-E-0656-0002 | FDA | FDA-2010-E-0656 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:21Z | 0 | 0 | 0900006480bc285c | ||
| FDA-2010-E-0657-0002 | FDA | FDA-2010-E-0657 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2010-12-30T18:00:32Z | 0 | 0 | 0900006480bc28ab | ||
| FDA-2010-E-0657-0001 | FDA | FDA-2010-E-0657 | Amgen Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-08-11T01:39:02Z | 0 | 0 | 0900006480bc28a9 | ||
| FDA-2010-E-0657-0003 | FDA | FDA-2010-E-0657 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2010-12-30T18:00:33Z | 0 | 0 | 0900006480bc28ae | ||
| FDA-2010-E-0659-0003 | FDA | FDA-2010-E-0659 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:22Z | 0 | 0 | 0900006480bc29ce | ||
| FDA-2010-E-0663-0002 | FDA | FDA-2010-E-0663 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-08-11T04:43:37Z | 0 | 0 | 0900006480bc2a9e | ||
| FDA-2010-E-0663-0001 | FDA | FDA-2010-E-0663 | Danek, et al. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:23Z | 0 | 0 | 0900006480bc2a9c | ||
| FDA-2010-E-0659-0002 | FDA | FDA-2010-E-0659 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:22Z | 0 | 0 | 0900006480bc29cc | ||
| FDA-2010-E-0661-0001 | FDA | FDA-2010-E-0661 | Aventis Pharma S.A. - Patent Term Extension Application | Other | APP-Application | 2010-12-30T05:00:00Z | 2010 | 12 | 2010-12-30T05:00:00Z | 2013-07-27T23:41:23Z | 0 | 0 | 0900006480bc2a24 | ||
| FDA-2010-E-0653-0001 | FDA | FDA-2010-E-0653 | Gilead Sciences, Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:14Z | 0 | 0 | 0900006480bc1ee3 | ||
| FDA-2008-E-0266-0008 | FDA | FDA-2008-E-0266 | U.S. Patent and Trademark Office to Johnson & Johnson - Notice of Final Determination Letter | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:14Z | 0 | 0 | 0900006480bc1ecf | ||
| FDA-2010-E-0653-0002 | FDA | FDA-2010-E-0653 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:14Z | 0 | 0 | 0900006480bc1ee5 | ||
| FDA-2010-E-0654-0002 | FDA | FDA-2010-E-0654 | U.S Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:17Z | 0 | 0 | 0900006480bc2342 | ||
| FDA-2010-E-0655-0002 | FDA | FDA-2010-E-0655 | U.S Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:17Z | 0 | 0 | 0900006480bc2344 | ||
| FDA-1997-N-0020-0014 | FDA | Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 | FDA/CFSAN to the Division of Dockets Management, February 6, 2006 | Other | Memorandum | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2011-10-26T21:51:50Z | 0 | 0 | 0900006480bc0beb | ||
| FDA-1978-N-0021-0032 | FDA | Over-the-Counter (OTC) Laxative FDA-1978-N-0021 | Letter from FDA/CDER to Peter S. Reichertz, Esq. and Christopher A. Brown, Esq. | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2016-09-13T15:18:53Z | 0 | 0 | 0900006480bc2181 | ||
| FDA-2010-E-0654-0001 | FDA | FDA-2010-E-0654 | Gilead Sciences, Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-07-27T23:41:17Z | 0 | 0 | 0900006480bc225b | ||
| FDA-2010-E-0655-0001 | FDA | FDA-2010-E-0655 | Gilead Sciences, Inc. - Patent Term Extension Application | Other | APP-Application | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2013-08-11T03:12:28Z | 0 | 0 | 0900006480bc2343 | ||
| FDA-2010-N-0511-0003 | FDA | FDA-2010-N-0511 | FDA/DDM Letter to Division of Wyeth Holdings - Letter | Other | LET-Letter | 2010-12-29T05:00:00Z | 2010 | 12 | 2010-12-29T05:00:00Z | 2010-12-29T14:34:06Z | 0 | 0 | 0900006480bc1b46 | ||
| FDA-2008-E-0261-0008 | FDA | FDA-2008-E-0261 | U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination | Other | LET-Letter | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2013-07-27T23:40:43Z | 0 | 0 | 0900006480bc0e70 | ||
| FDA-2009-E-0014-0007 | FDA | FDA-2009-E-0014 | U.S. Patent & Trademark Office to Abbott Diabetes Care Inc. - Letter with enclosure | Other | LET-Letter | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2013-07-27T23:40:43Z | 0 | 0 | 0900006480bc0e15 | ||
| FDA-2008-E-0258-0008 | FDA | FDA-2008-E-0258 | U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination | Other | LET-Letter | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2013-07-27T23:40:43Z | 0 | 0 | 0900006480bc0e6e | ||
| FDA-2008-E-0260-0008 | FDA | FDA-2008-E-0260 | U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination | Other | LET-Letter | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2013-08-11T03:12:26Z | 0 | 0 | 0900006480bc0e72 | ||
| FDA-2010-N-0002-0089 | FDA | FDA-2010-N-0002 | Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares | Other | FOIS-Freedom of Information Summary (No Federal Register Publication) | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T16:01:31Z | 0 | 0 | 0900006480bc13dc | ||
| FDA-2010-N-0511-0002 | FDA | FDA-2010-N-0511 | FDA/DDM Letter to Division of Wyeth Holdings - Letter | Other | 2010-12-28T00:00:00Z | 2010 | 12 | 2010-12-29T14:18:57Z | 0 | 1 | 0900006480b77e4c | ||||
| FDA-2010-P-0630-0009 | FDA | FDA-2010-P-0630 | Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Correction | Other | Correction(s) | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2012-05-09T22:38:35Z | 0 | 0 | 0900006480bbd326 | ||
| FDA-2010-E-0037-0007 | FDA | FDA-2010-E-0037 | U.S. Patent & Trademark Office to FDA/CDER - Letter with enclosure | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:40:38Z | 0 | 0 | 0900006480bc087d | ||
| FDA-2009-E-0020-0009 | FDA | FDA-2009-E-0020 | U.S. Patent & Trademark Office to Millen, White, Zelano & Branigan, P.C. - Notice of Final Determinaton | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-08-11T03:12:25Z | 0 | 0 | 0900006480bc0880 | ||
| FDA-2004-E-0266-0009 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | U.S. Patent & Trademark Office to Connolly Bove Lodge & Hutz LLP - Notice of Final Determinaton | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:40:38Z | 0 | 0 | 0900006480bc087f | ||
| FDA-2010-P-0582-0005 | FDA | FDA-2010-P-0582 | Acknowledgement Letter to Lachman Consultant Services, Inc. | Other | ACK-Acknowledgement Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:37:21Z | 0 | 0 | 0900006480b8a212 | ||
| FDA-2007-E-0048-0008 | FDA | FDA-2007-E-0048 | U.S. Patent & Trademark Office to Harness, Dickey & Pierce, PLC - Notice of Final Determinaton | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-08-11T01:38:57Z | 0 | 0 | 0900006480bc0881 | ||
| FDA-2010-V-0587-0002 | FDA | FDA-2010-V-0587 | Acknowledgement Letter to Syndicate Hospitality Group | Other | ACK-Acknowledgement Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:37:31Z | 0 | 0 | 0900006480b93263 | ||
| FDA-2010-V-0587-0001 | FDA | FDA-2010-V-0587 | Syndicate Hospitality Group - Application for Variance | Other | VAR-Application for Variance | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:37:31Z | 0 | 0 | 0900006480b9321a | ||
| FDA-2010-P-0582-0001 | FDA | FDA-2010-P-0582 | Lachman Consultant Services, Inc. - Citizen Petition | Other | CP-Citizen Petition | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2024-11-12T04:55:42Z | 1 | 0 | 0900006480b88126 | ||
| FDA-2007-E-0104-0008 | FDA | FDA-2007-E-0104 | USPTO to FDA/CDER - Letter | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:40:38Z | 0 | 0 | 0900006480bc0864 | ||
| FDA-2007-E-0482-0006 | FDA | FDA-2007-E-0482 | USPT to FDA/CDER - Letter | Other | LET-Letter | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-27T18:17:53Z | 0 | 0 | 0900006480bbe90f | |||
| FDA-2004-E-0270-0009 | FDA | Patent Extension for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,211,244 FDA-2004-E-0270 | Notice of Determination and Requirement for Election | Other | LET-Letter | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-27T17:55:37Z | 0 | 0 | 0900006480bbec80 | |||
| FDA-2010-D-0575-0002 | FDA | FDA-2010-D-0575 | Guidance for FDA Staff Compliance Policy Guide Sec. 510.80 Beverages - Serving Size Labeling | Other | GDL-Guidance (Supporting and Related Materials) | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2011-02-23T04:59:59Z | 2010-12-23T14:47:35Z | 0 | 0 | 0900006480bbe8dc | |
| FDA-2009-D-0466-0009 | FDA | FDA-2009-D-0466 | Guidance for FDA Staff; Compliance Policy Guide Sec. 527.300 Dairy Products - Microbial Contaminants and Alkaline Phophatase Activity | Other | Guidance | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2024-11-07T22:26:34Z | 1 | 0 | 0900006480bbe8e0 | ||
| FDA-2010-E-0037-0006 | FDA | FDA-2010-E-0037 | FDA/CDER to U.S. Patent & Trademark Office - Letter | Other | LET-Letter | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-23T05:00:00Z | 2010-12-23T15:48:11Z | 0 | 0 | 0900006480bbeaf5 | ||
| FDA-2008-E-0307-0008 | FDA | FDA-2008-E-0307 | Noice of Determination - Letter | Other | LET-Letter | 2010-12-23T05:00:00Z | 2010 | 12 | 2010-12-27T18:02:38Z | 0 | 0 | 0900006480bbeaf0 | |||
| FDA-2010-P-0628-0003 | FDA | FDA-2010-P-0628 | Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Correction | Other | CR-Correction | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-22T05:00:00Z | 2013-07-27T23:40:14Z | 0 | 0 | 0900006480bbd27f | ||
| FDA-2007-E-0104-0007 | FDA | FDA-2007-E-0104 | USPTO to FDA/CDER - Letter | Other | LET-Letter | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-27T18:48:10Z | 0 | 0 | 0900006480bbd154 | |||
| FDA-2008-E-0102-0003 | FDA | FDA-2008-E-0102 | USPTO to FDA/CDER - Letter | Other | LET-Letter | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-27T18:20:09Z | 0 | 0 | 0900006480bbd1eb | |||
| FDA-2010-P-0559-0004 | FDA | FDA-2010-P-0559 | Change in Classification Petition from Saliwell Ltd. | Other | Change in Classification Petition | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-22T05:00:00Z | 2015-03-01T00:42:19Z | 0 | 0 | 0900006480b78471 | ||
| FDA-2010-P-0559-0007 | FDA | FDA-2010-P-0559 | Acknowledgement Letter to Saliwell Ltd. | Other | ACK-Acknowledgement Letter | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-22T05:00:00Z | 2013-07-27T23:40:25Z | 0 | 0 | 0900006480bbe1dd | ||
| FDA-2008-E-0315-0003 | FDA | FDA-2008-E-0315 | USPTO to FDA/CDER - Letter | Other | LET-Letter | 2010-12-22T05:00:00Z | 2010 | 12 | 2010-12-22T05:00:00Z | 2010-12-22T15:54:05Z | 0 | 0 | 0900006480bbd24a | ||
| FDA-2010-P-0580-0003 | FDA | FDA-2010-P-0580 | Acknowledgement Letter to Bracewell & Giuliani, LLP | Other | ACK-Acknowledgement Letter | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2013-08-11T04:42:55Z | 0 | 0 | 0900006480b8a278 | ||
| FDA-2010-P-0580-0001 | FDA | FDA-2010-P-0580 | Bracewell & Giuliani, LLP - Citizen Petition | Other | CP-Citizen Petition | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2024-11-12T04:54:58Z | 1 | 0 | 0900006480b8a152 | ||
| FDA-2007-E-0226-0003 | FDA | FDA-2007-E-0226 | USPTO to FDA/CDER | Other | LET-Letter | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-27T18:52:44Z | 0 | 0 | 0900006480bbad42 | |||
| FDA-2008-E-0092-0008 | FDA | FDA-2008-E-0092 | USPTO to FDA/CDER - Letter | Other | LET-Letter | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-27T18:50:57Z | 0 | 0 | 0900006480bbcf60 | |||
| FDA-2003-V-0297-0006 | FDA | Laser Light Show FDA-2003-V-0297 | Lumalaser, Inc. - Amendment | Other | AMD-Amendment | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2013-07-27T23:36:18Z | 0 | 0 | 0900006480b7d8d8 | ||
| FDA-2010-V-0569-0002 | FDA | FDA-2010-V-0569 | Acknowledgement Letter to Sheffield Family Life Center | Other | ACK-Acknowledgement Letter | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2013-08-11T04:42:46Z | 0 | 0 | 0900006480b7d8d7 | ||
| FDA-2010-V-0569-0001 | FDA | FDA-2010-V-0569 | Sheffield Family Life Center - Application for Variance | Other | VAR-Application for Variance | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2013-07-27T23:36:18Z | 0 | 0 | 0900006480b7d8d6 | ||
| EPA-HQ-OA-2010-1069-0002 | EPA | Semiannual Regulatory Agenda - Fall 2010 EPA-HQ-OA-2010-1069 | Regulatory Plan - Fall 2010 | Other | Significant Guidance | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T17:30:36Z | 0 | 0 | 0900006480bbaa04 | ||
| EPA-HQ-OA-2010-1069-0001 | EPA | Semiannual Regulatory Agenda - Fall 2010 EPA-HQ-OA-2010-1069 | Semiannual Regulatory Agenda - Fall 2010 | Other | Significant Guidance | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T17:30:36Z | 0 | 0 | 0900006480bba9ef | ||
| EPA-HQ-OW-2010-0728-0001 | EPA | EPA-HQ-OW-2010-0728 | Memorandum Opening Docket EPA-HQ-OW-2010-0728 for Public Access | Other | Memorandum to Open a Docket | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-02-22T04:59:59Z | 2012-02-23T19:14:02Z | 0 | 0 | 0900006480b472cf | |
| FDA-2010-P-0628-0001 | FDA | FDA-2010-P-0628 | Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition | Other | CP-Citizen Petition | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2013-07-27T23:39:14Z | 0 | 0 | 0900006480bb2bb2 | ||
| FDA-2010-P-0638-0001 | FDA | FDA-2010-P-0638 | Dinsmore & Shohl, LLP - Citizen Petition | Other | CP-Citizen Petition | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2013-07-27T23:39:36Z | 0 | 0 | 0900006480bb641b | ||
| FDA-2008-E-0315-0004 | FDA | FDA-2008-E-0315 | US Patent & Trademark Office - Transmittal Form | Other | LET-Letter | 2010-12-20T05:00:00Z | 2010 | 12 | 2013-07-27T23:40:14Z | 0 | 0 | 0900006480bbd27d | |||
| FDA-2010-P-0624-0001 | FDA | FDA-2010-P-0624 | Cubist Pharmaceuticals, Inc. - Citizen Petition | Other | CP-Citizen Petition | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2013-08-11T03:12:04Z | 0 | 0 | 0900006480bb16be | ||
| FDA-2010-P-0630-0002 | FDA | FDA-2010-P-0630 | Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG | Other | Acknowledgement Letter/Receipt | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2012-05-09T22:31:38Z | 0 | 0 | 0900006480bb3e0a | ||
| FDA-2010-P-0632-0001 | FDA | FDA-2010-P-0632 | Acknowledgement Letter to Sandoz, Inc. | Other | ACK-Acknowledgement Letter | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2011-06-13T21:16:33Z | 0 | 0 | 0900006480bb5126 | ||
| FDA-2010-P-0624-0002 | FDA | FDA-2010-P-0624 | Acknowledgement Letter to Cubist Pharmaceuticals, Inc. | Other | ACK-Acknowledgement Letter | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T15:14:57Z | 0 | 0 | 0900006480bb16bf | ||
| FDA-2010-P-0628-0002 | FDA | FDA-2010-P-0628 | Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG | Other | Acknowledgement Letter/Receipt | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2013-08-11T04:43:15Z | 0 | 0 | 0900006480bb32df | ||
| FDA-2010-P-0630-0001 | FDA | FDA-2010-P-0630 | Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition | Other | Citizen Petition | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2024-11-07T22:26:27Z | 1 | 0 | 0900006480bb3df1 | ||
| FDA-2010-P-0638-0002 | FDA | FDA-2010-P-0638 | Acknowledgement Letter to Dinsmore & Shohl, LLP | Other | ACK-Acknowledgement Letter | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2013-08-11T03:12:11Z | 0 | 0 | 0900006480bb6422 | ||
| USDA-2010-0005-0001 | USDA | Semiannual Regulatory Agenda - Fall 2010 USDA-2010-0005 | Semiannual Regulatory Agenda - Fall 2010 | Other | NA | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T17:30:43Z | 0 | 0 | 0900006480bbaab4 | ||
| USDA-2010-0005-0002 | USDA | Semiannual Regulatory Agenda - Fall 2010 USDA-2010-0005 | Regulatory Plan - Fall 2010 | Other | NA | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T17:30:43Z | 0 | 0 | 0900006480bbaab5 | ||
| FDA-2010-P-0559-0001 | FDA | FDA-2010-P-0559 | Acknowledgement Letter to Saliwell Ltd. | Other | 2010-12-20T00:00:00Z | 2010 | 12 | 2013-07-27T23:35:48Z | 0 | 1 | 0900006480b789bb | ||||
| FDA-2010-P-0642-0001 | FDA | FDA-2010-P-0642 | Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. - Citizen Petition | Other | CP-Citizen Petition | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2011-06-16T12:40:15Z | 0 | 0 | 0900006480bb890d | ||
| FDA-2008-P-0421-0006 | FDA | FDA-2008-P-0421 | FDA/CDER to Buchanan Ingersoll & Rooney PC - Peititon Denial | Other | PDN-Petition Denial | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2013-07-27T23:39:59Z | 0 | 0 | 0900006480bb95a1 | ||
| FDA-2010-P-0642-0002 | FDA | FDA-2010-P-0642 | Acknowledgement Letter to Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. | Other | ACK-Acknowledgement Letter | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2013-07-27T23:39:53Z | 0 | 0 | 0900006480bb890e | ||
| FDA-2007-P-0339-0004 | FDA | FDA-2007-P-0339 | FDA/CDER to Anil K. Mandal, M.D. - Peititon Denial | Other | PDN-Petition Denial | 2010-12-17T05:00:00Z | 2010 | 12 | 2010-12-17T05:00:00Z | 2013-07-27T23:39:59Z | 0 | 0 | 0900006480bb95a0 | ||
| APHIS-2007-0044-12532 | APHIS | Regulatory Status of Alfalfa Genetically Engineered for Tolerance to the Herbicide Glyphosate APHIS-2007-0044 | Glyphosate-Tolerant Alfalfa Events: Final Environmental Impact Statement (December 2010) | Other | EIS | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2011-01-25T04:59:59Z | 2011-01-05T16:11:55Z | 0 | 0 | 0900006480bb8007 | |
| EPA-R09-OAR-2010-1061-0001 | EPA | EPA-R09-OAR-2010-1061 | Pacific Oroville Power Final PSD Permit Amendment Issued December 13, 2010 | Other | NA | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2011-01-27T11:43:12Z | 0 | 0 | 0900006480bb8a19 | ||
| EPA-R09-OAR-2010-1062-0001 | EPA | EPA-R09-OAR-2010-1062 | Knauf Insulation PSD Permit Amendment Issued December 13, 2010 | Other | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2010-12-16T22:54:02Z | 0 | 0 | 0900006480bb8a1f | |||
| FDA-2010-N-0621-0001 | FDA | FDA-2010-N-0621 | FDA/Center for Drug Evaluation and Research (CDER) to Genentech, Inc. - Letter | Other | Letter(s) | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2011-06-30T20:20:28Z | 0 | 0 | 0900006480bb81e7 | ||
| FDA-2010-D-0605-0002 | FDA | FDA-2010-D-0605 | Guidance for Industry; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Small Entiy Compliance Guide | Other | Guidance | 2010-12-16T05:00:00Z | 2010 | 12 | 2010-12-16T05:00:00Z | 2024-11-07T22:29:06Z | 1 | 0 | 0900006480bb8335 | ||
| FDA-1987-P-0042-0003 | FDA | SODIUM CHLORIDE INJECTION USP, 0.9% ANDA SUITABILITY-CLOSED FDA-1987-P-0042 | FDA/CDER to Lyphomed Inc. - Petition Approval | Other | PAV-Petition Approval | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2013-08-11T02:32:48Z | 0 | 0 | 090000648046c5da | ||
| FDA-1987-P-0042-0002 | FDA | SODIUM CHLORIDE INJECTION USP, 0.9% ANDA SUITABILITY-CLOSED FDA-1987-P-0042 | Acknowledgement Letter to Lyphomed, Inc. | Other | ACK-Acknowledgement Letter | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2013-07-27T23:39:36Z | 0 | 0 | 0900006480bb6400 | ||
| FDA-2010-D-0616-0002 | FDA | FDA-2010-D-0616 | Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination - Draft Guidance | Other | GDL-Guidance (Supporting and Related Materials) | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2019-10-21T13:19:49Z | 0 | 0 | 0900006480bb7e80 | ||
| FDA-1987-P-0042-0001 | FDA | SODIUM CHLORIDE INJECTION USP, 0.9% ANDA SUITABILITY-CLOSED FDA-1987-P-0042 | LyphoMed, Inc. - Citizen Petition | Other | CP-Citizen Petition | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2013-07-27T20:47:08Z | 0 | 0 | 090000648046c5d9 | ||
| FDA-2010-P-0172-0006 | FDA | FDA-2010-P-0172 | FDA/CDER to Lachman Consultant Services, Inc. Response Letter | Other | LET-Letter | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2013-08-11T03:12:10Z | 0 | 0 | 0900006480bb6372 | ||
| FDA-2010-P-0359-0003 | FDA | FDA-2010-P-0359 | Goodwin Procter LLP - Letter | Other | LET-Letter | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2010-12-14T18:57:46Z | 0 | 0 | 0900006480bb615d | ||
| FDA-2010-P-0263-0004 | FDA | FDA-2010-P-0263 | Interim Response to First Juice Inc. | Other | LET-Letter | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2013-08-11T04:43:18Z | 0 | 0 | 0900006480bb636e | ||
| FDA-2006-P-0150-0005 | FDA | FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 | Citizen Petition Approval from FDA CDER to Lachman Consultant Services, Inc. | Other | Approval | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2025-01-07T15:29:36Z | 0 | 0 | 0900006480bb6370 | ||
| FDA-2010-P-0177-0005 | FDA | FDA-2010-P-0177 | FDA/CDER to EAS Consulting Group, LLC - Response Letter | Other | LET-Letter | 2010-12-14T05:00:00Z | 2010 | 12 | 2010-12-14T05:00:00Z | 2013-08-11T01:38:43Z | 0 | 0 | 0900006480bb63c8 | ||
| EPA-R09-OAR-2010-0226-0005 | EPA | EPA-R09-OAR-2010-0226 | Final Prevention of Significant Deterioration Permit of Sierra Pacific Industries - Loyalton Project (SAC 87-01-A) | Other | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2010-12-10T20:16:30Z | 0 | 0 | 0900006480b4a471 | |||
| FDA-2005-D-0072-0006 | FDA | Draft Guidance on the Open Public Hearing, FDA Advisory Committee Meetings FDA-2005-D-0072 | Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: The Open Public Hearing at FDA Advisory Committee Meeting; Final Guidance | Other | GDL-Guidance (Supporting and Related Materials) | 2010-12-10T05:00:00Z | 2010 | 12 | 2010-12-10T05:00:00Z | 2010-12-11T00:41:54Z | 0 | 0 | 0900006480bb3e0d | ||
| FDA-2010-P-0619-0002 | FDA | FDA-2010-P-0619 | Acknowledgement Letter to Richard F. Edlich, M.D., Ph.D. | Other | ACK-Acknowledgement Letter | 2010-12-09T05:00:00Z | 2010 | 12 | 2010-12-09T05:00:00Z | 2013-07-27T23:39:00Z | 0 | 0 | 0900006480bb0d1f | ||
| FDA-2010-P-0619-0001 | FDA | FDA-2010-P-0619 | Richard F. Edlich, M.D., Ph.D., (University of Virginia Health Systems) - Citizen Petition | Other | CP-Citizen Petition | 2010-12-09T05:00:00Z | 2010 | 12 | 2010-12-09T05:00:00Z | 2018-04-26T16:34:06Z | 0 | 0 | 0900006480bb01fd | ||
| FDA-2010-N-0568-0009 | FDA | FDA-2010-N-0568 | Sample Write-In Campaign 1 - (Surgeon General's Warning) - [Multiple Submitters=68] - Form Letter | Other | FL-Form Letter | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2013-07-27T23:39:11Z | 0 | 0 | 0900006480bb1f79 | ||
| FDA-2010-P-0614-0001 | FDA | FDA-2010-P-0614 | Acknowledgement Letter to Sidley Austin LLP [Mutual Pharmaceutical Company, Inc.] | Other | ACK-Acknowledgement Letter | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T21:01:59Z | 0 | 0 | 0900006480baa855 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);